Clinical Courses and Outcome of Newly Diagnosed Immune Thrombocytopenia in Infants-Reference-Cited by-同舟云学术

Clinical Courses and Outcome of Newly Diagnosed Immune Thrombocytopenia in Infants

Published:2018-10-31 Issue:2 Volume:25 Page:97-101
ISSN:2233-5250
Container-title:Clinical Pediatric Hematology-Oncology
language:en
Short-container-title:Clin Pediatr Hematol Oncol

Author:

Hwang Nu Ri¹,Park Kyung Duk¹²^ORCID

Affiliation:

1. Chonbuk National University Childrens Hospital, Jeonju, Korea

2. Research Institute of Clinical Medicine of Chonbuk National University, Jeonju, Korea

Funder

Chonbuk National University Hospital

Publisher

The Korean Society of Pediatric Hematology-Oncology

Subject

General Materials Science

Link

http://pdf.medrang.co.kr/CPHO/2018/025/CPHO025-02-03.pdf

Reference19 articles.

1. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group

2. Kwak JW, Lim YT. A comparative analysis according to age for acute idiopathic thrombocytopenic purpura in children: especially in infants under 1 year of age. Korean J Pediatr Hematol Oncol 2005;12:11-7.

3. Initial lymphocyte count and the development of persistent/chronic immune thrombocytopenic purpura

4. Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in children

5. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Features and Treatment Outcomes of Immune Thrombocytopenic Purpura in Infants: A Single Center Retrospective Study;Clinical Pediatric Hematology-Oncology;2019-10-31